|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ and
Kang GH: Aberrant CpG island hypermethylation along multistep
hepatocarcinogenesis. Am J Pathol. 163:1371–1378. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Søkilde R, Vincent M, Møller AK, Hansen A,
Høiby PE, Blondal T, Nielsen BS, Daugaard G, Møller S and Litman T:
Efficient identification of miRNAs for classification of tumor
origin. J Mol Diagn. 16:106–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Osman A: MicroRNAs in health and disease -
basic science and clinical applications. Clin Lab. 58:393–402.
2012.PubMed/NCBI
|
|
5
|
Zhao G, Cai C, Yang T, Qiu X, Liao B, Li
W, Ji Z, Zhao J, Zhao H, Guo M, et al: MicroRNA-221 induces cell
survival and cisplatin resistance through PI3K/Akt pathway in human
osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van Rooij E and Kauppinen S: Development
of microRNA therapeutics is coming of age. EMBO Mol Med. 6:851–864.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nugent M: MicroRNA function and
dysregulation in bone tumors: The evidence to date. Cancer Manag
Res. 6:15–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu AM, Poon RT and Luk JM: MicroRNA-375
targets Hippo-signaling effector YAP in liver cancer and inhibits
tumor properties. Biochem Biophys Res Commun. 394:623–627. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fornari F, Milazzo M, Chieco P, Negrini M,
Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L and Gramantieri
L: MiR-199a-3p regulates mTOR and c-Met to influence the
doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res.
70:5184–5193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morin RD, O'Connor MD, Griffith M,
Kuchenbauer F, Delaney A, Prabhu AL, Zhao Y, McDonald H, Zeng T,
Hirst M, et al: Application of massively parallel sequencing to
microRNA profiling and discovery in human embryonic stem cells.
Genome Res. 18:610–621. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martinez-Sanchez A and Murphy CL: miR-1247
functions by targeting cartilage transcription factor SOX9. J Biol
Chem. 288:30802–30814. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu Y, Ginther C, Kim J, Mosher N, Chung S,
Slamon D and Vadgama JV: Expression of Wnt3 activates Wnt/β-catenin
pathway and promotes EMT-like phenotype in trastuzumab-resistant
HER2-overexpressing breast cancer cells. Mol Cancer Res.
10:1597–1606. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan H, Choi AJ, Lee BH and Ting AH:
Identification and functional analysis of epigenetically silenced
microRNAs in colorectal cancer cells. PLoS One. 6:e206282011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi S, Lu Y, Qin Y, Li W, Cheng H, Xu Y,
Xu J, Long J, Liu L, Liu C, et al: miR-1247 is correlated with
prognosis of pancreatic cancer and inhibits cell proliferation by
targeting neuropilins. Curr Mol Med. 14:316–327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Scaravilli M, Porkka KP, Brofeldt A,
Annala M, Tammela TL, Jenster GW, Nykter M and Visakorpi T:
MiR-1247-5p is overexpressed in castration resistant prostate
cancer and targets MYCBP2. Prostate. 75:798–805. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Anwar SL, Albat C, Krech T, Hasemeier B,
Schipper E, Schweitzer N, Vogel A, Kreipe H and Lehmann U:
Concordant hypermethylation of intergenic microRNA genes in human
hepatocellular carcinoma as new diagnostic and prognostic marker.
Int J Cancer. 133:660–670. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han G, Wang Y, Bi W, Jia J and Wang W:
MicroRNA-124 functions as a tumor suppressor and indicates
prognosis in human osteosarcoma. Exp Ther Med. 9:679–684.
2015.PubMed/NCBI
|
|
21
|
Mardin WA and Mees ST: MicroRNAs: Novel
diagnostic and therapeutic tools for pancreatic ductal
adenocarcinoma? Ann Surg Oncol. 16:3183–3189. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rachagani S, Kumar S and Batra SK:
MicroRNA in pancreatic cancer: Pathological, diagnostic and
therapeutic implications. Cancer Lett. 292:8–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bianchi F, Nicassio F, Marzi M, Belloni E,
Dall'olio V, Bernard L, Pelosi G, Maisonneuve P, Veronesi G and Di
Fiore PP: A serum circulating miRNA diagnostic test to identify
asymptomatic high-risk individuals with early stage lung cancer.
EMBO Mol Med. 3:495–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu R, Zhang C, Hu Z, Li G, Wang C, Yang
C, Huang D, Chen X, Zhang H, Zhuang R, et al: A five-microRNA
signature identified from genome-wide serum microRNA expression
profiling serves as a fingerprint for gastric cancer diagnosis. Eur
J Cancer. 47:784–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen ZH, Zhang GL, Li HR, Luo JD, Li ZX,
Chen GM and Yang J: A panel of five circulating microRNAs as
potential biomarkers for prostate cancer. Prostate. 72:1443–1452.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang C, Wang C, Chen X, Yang C, Li K,
Wang J, Dai J, Hu Z, Zhou X, Chen L, et al: Expression profile of
microRNAs in serum: A fingerprint for esophageal squamous cell
carcinoma. Clin Chem. 56:1871–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Long JD, Sullivan TB, Humphrey J,
Logvinenko T, Summerhayes KA, Kozinn S, Harty N, Summerhayes IC,
Libertino JA, Holway AH, et al: A non-invasive miRNA based assay to
detect bladder cancer in cell-free urine. Am J Transl Res.
7:2500–2509. 2015.PubMed/NCBI
|
|
29
|
Suryawanshi S, Vlad AM, Lin HM,
Mantia-Smaldone G, Laskey R, Lee M, Lin Y, Donnellan N, Klein-Patel
M, Lee T, et al: Plasma microRNAs as novel biomarkers for
endometriosis and endometriosis-associated ovarian cancer. Clin
Cancer Res. 19:1213–1224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zeng X, Xiang J, Wu M, Xiong W, Tang H,
Deng M, Li X, Liao Q, Su B, Luo Z, et al: Circulating miR-17,
miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers
in nasopharyngeal carcinoma. PLoS One. 7:e463672012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakashima N, Liu D, Huang CL, Ueno M,
Zhang X and Yokomise H: Wnt3 gene expression promotes tumor
progression in non-small cell lung cancer. Lung Cancer. 76:228–234.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
White BD, Chien AJ and Dawson DW:
Dysregulation of Wnt/β-catenin signaling in gastrointestinal
cancers. Gastroenterology. 142:219–232. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lachenmayer A, Alsinet C, Savic R,
Cabellos L, Toffanin S, Hoshida Y, Villanueva A, Minguez B, Newell
P, Tsai HW, et al: Wnt-pathway activation in two molecular classes
of hepatocellular carcinoma and experimental modulation by
sorafenib. Clin Cancer Res. 18:4997–5007. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Voloshanenko O, Erdmann G, Dubash TD,
Augustin I, Metzig M, Moffa G, Hundsrucker C, Kerr G, Sandmann T,
Anchang B, et al: Wnt secretion is required to maintain high levels
of Wnt activity in colon cancer cells. Nat Commun. 4:26102013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kunej T, Godnic I, Ferdin J, Horvat S,
Dovc P and Calin GA: Epigenetic regulation of microRNAs in cancer:
An integrated review of literature. Mutat Res. 717:77–84. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kozaki K and Inazawa J: Tumor-suppressive
microRNA silenced by tumor-specific DNA hypermethylation in cancer
cells. Cancer Sci. 103:837–845. 2012. View Article : Google Scholar : PubMed/NCBI
|
